(Total Views: 834)
Posted On: 08/09/2020 4:58:45 PM
Post# of 148908
Re: MD VIROLOGIST #48006
Interesting, thanks for sharing.
My credentials and motives on here would also be questioned as I’ve criticized NP on multiple occasions. Could you please let us know if anyone reached out to BP to confirm the validity of your claims? Or, even better this way, could anyone of the longs on this forum let us know if they confirm this info?
What’s clear is that RLF has ways to go before anyone can claim with confidence the success of the drug against Covid, mostly on the efficacy side (less so on safety, which is encouraging). What’s also clear, however, is that they got more traction than Cytodyn has ever gotten since I started following them in March 2020. I don’t care about the reasons that contributed to that (though I’m more than happy to speculate if asked) but it’s a fact, and it’s also something that can play a major role towards the success of the drug, should some efficacy be shown.
I could easily be wrong on this one but seems to me that BP is making his moves by being willing to back-up a different molecule. I’m glad he’s doing it, I was frustrated with NP not seeing the value of bringing him onboard.
Alekos
My credentials and motives on here would also be questioned as I’ve criticized NP on multiple occasions. Could you please let us know if anyone reached out to BP to confirm the validity of your claims? Or, even better this way, could anyone of the longs on this forum let us know if they confirm this info?
What’s clear is that RLF has ways to go before anyone can claim with confidence the success of the drug against Covid, mostly on the efficacy side (less so on safety, which is encouraging). What’s also clear, however, is that they got more traction than Cytodyn has ever gotten since I started following them in March 2020. I don’t care about the reasons that contributed to that (though I’m more than happy to speculate if asked) but it’s a fact, and it’s also something that can play a major role towards the success of the drug, should some efficacy be shown.
I could easily be wrong on this one but seems to me that BP is making his moves by being willing to back-up a different molecule. I’m glad he’s doing it, I was frustrated with NP not seeing the value of bringing him onboard.
Alekos
(0)
(0)Scroll down for more posts ▼
